NIH study in mice explains how brain can turn pain signals up or down

A new study in mice uncovered a previously unknown role that the central amygdala can play in upgrading or downgrading pain signals in the brain’s circuitry. The study, published in Cell Reports, was conducted by researchers at the Division of Intramural Research at the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health.

 “We know that pain is not static and that it can be modulated by several factors. Early research showed that the central amygdala, long known for its role in processing fear, can dial up pain signals. Yet, other studies have pointed to the central amygdala’s role in suppressing pain, or prompting an analgesic response,” said Yarimar Carrasquillo, Ph.D., senior author of the study and lead scientist for the Behavioral Neurocircuitry and Cellular Plasticity Section in the NCCIH Intramural Division. “This study unravels what seemed to be a contradiction in early research and reveals a previously hidden ‘switch’ in the central amygdala that can turn up or turn down pain signals.”

The “switch” acts more like a “pain rheostat,” similar to a home thermostat that modulates temperature — the pain rheostat reacts to pain signals to modulate pain sensations. In the mice, researchers found that activity in neurons that express protein kinase C-delta (CeA-PKCδ) turned up the pain rheostat and demonstrated an increase in pain-related responses. Conversely, researchers found that activity in neurons that express somatostatin (CeA-Som) turned down the pain rheostat, inhibiting nociception or the chain of activity in the nerves required to communicate pain.

During the experiments, researchers were able to take advantage of molecular genetic approaches that allow them to fluorescently label and manipulate the activity of these two central amygdala cell types. They found that when they blocked CeA-PKCδ neurons, pain activity decreased. When researchers activated CeA-Som neurons, they observed a marked analgesic response in mice.

“This new understanding of the amygdala’s dual role, and the pathways that can promote the perception of pain or prompt an analgesic response, is critical to understanding how pain manifests,” said Helene Langevin, M.D., NCCIH director. “It also provides new clues for researchers to pursue in learning how we might manage pain by modulating what’s happening in the brain.”

While pain perception is essential for survival, it can be amplified or suppressed by factors like expectations, past experiences, and context. The research team led by Dr. Carrasquillo conducts basic science research into anatomical, molecular, and cellular mechanisms to better understand the mechanisms of pain modulation in the brain.

The study is part of NCCIH’s broad range of intramural and extramural efforts to address the issue of pain and chronic pain in the United States, including NCCIH’s role in the NIH-wide HEAL (Helping to End Addiction Long-termSM) Initiative and the NIH-DoD-VA Pain Management Collaboratory. Approximately 40% of NCCIH’s overall budget focuses on pain.

Pain is the most common reason patients in the U.S. seek medical care and one of the most common reasons people turn to complementary health approaches. The 2012 National Health Interview Survey showed that about 11% of U.S. adults have pain every day and more than 17% have severe levels of pain.

Substack subscription form sign up
The material in this press release comes from the originating research organization. Content may be edited for style and length. Want more? Sign up for our daily email.